120 related articles for article (PubMed ID: 23210825)
21. FDA's claims over stem cells upheld.
Cyranoski D
Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
[No Abstract] [Full Text] [Related]
22. Global update: Scotland.
Courtney A
Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
[TBL] [Abstract][Full Text] [Related]
23. California dreaming? A new start for regenerative medicine in the Golden State. Interview with Dr. Zach Hall.
Hall ZW
Regen Med; 2007 Jan; 2(1):25-8. PubMed ID: 17465772
[TBL] [Abstract][Full Text] [Related]
24. Stem cell research in Cell Transplantation: an analysis of geopolitical influence by publications.
Eve DJ; Sanberg PR
Cell Transplant; 2007; 16(8):867-73. PubMed ID: 18088006
[TBL] [Abstract][Full Text] [Related]
25. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
26. Innovation in stem cell advocacy: you only get what you can measure.
Jakimo AL; Fernandez AC
Regen Med; 2011 Nov; 6(6 Suppl):127-32. PubMed ID: 21999275
[TBL] [Abstract][Full Text] [Related]
27. The World Stem Cell Summit. Interview with Bernard Siegel.
Siegel B
Regen Med; 2011 Nov; 6(6 Suppl):109-12. PubMed ID: 21999271
[TBL] [Abstract][Full Text] [Related]
28. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
Servick K
Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
[No Abstract] [Full Text] [Related]
29. Fighting for stem cell research. Interview with Don C Reed.
Reed DC
Regen Med; 2011 Nov; 6(6 Suppl):118-20. PubMed ID: 21999273
[TBL] [Abstract][Full Text] [Related]
30. California institute for regenerative medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells; 2012 Mar; 30(3):357-9. PubMed ID: 22334457
[No Abstract] [Full Text] [Related]
31. [Stem cells: scientific progress and commercial tactics].
Nau JY
Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
[No Abstract] [Full Text] [Related]
32. Stem cells. Italian Parliament orders €3 million trial of disputed therapy.
Margottini L
Science; 2013 May; 340(6136):1028. PubMed ID: 23723211
[No Abstract] [Full Text] [Related]
33. Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation.
Eve DJ; Fillmore RW; Borlongan CV; Sanberg PR
Cell Transplant; 2010; 19(11):1493-509. PubMed ID: 21054954
[TBL] [Abstract][Full Text] [Related]
34. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Johnson S
Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
[No Abstract] [Full Text] [Related]
35. Global update: Japan.
Sipp D
Regen Med; 2011 Nov; 6(6 Suppl):160-2. PubMed ID: 21999281
[TBL] [Abstract][Full Text] [Related]
36. Science and society: a stem cell technology model.
Kiatpongsan S
J Med Assoc Thai; 2008 Feb; 91(2):268-71. PubMed ID: 18389995
[TBL] [Abstract][Full Text] [Related]
37. The economic value of investing in regenerative medicine.
Hussain A; Rivers PA
J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720
[TBL] [Abstract][Full Text] [Related]
38. Stem cells on the ballot.
Goldstein LSB; Klein RN
Science; 2021 Jan; 371(6526):215. PubMed ID: 33446531
[No Abstract] [Full Text] [Related]
39. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
40. GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski.
Lebkowski J
Regen Med; 2011 Nov; 6(6 Suppl):11-3. PubMed ID: 21999256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
